Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001703031 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value: $894M (100.0% shares, 0.0% debt)

Holdings (31)

NUVL NUVALENT INC 18.4%

Value $164M Shares 3,577,267 Est. Cost $28.96 Unrealized +53.2%

PHVS PHARVARIS N V 11.2%

Value $99.86M Shares 4,784,674 Est. Cost $23.89 Unrealized -22.8%

NAMS NEWAMSTERDAM PHARMA COMPANY 10.8%

Value $96.88M Shares 10,473,913 Est. Cost $10.64 Unrealized +1.8%

— SPRINGWORKS THERAPEUTICS INC 8.0%

Value $71.24M Shares 3,081,307 Est. Cost $21.68 Unrealized —

IRON DISC MEDICINE INC 7.0%

Value $62.6M Shares 1,332,545 Est. Cost $22.28 Unrealized +124.5%

SVRA SAVARA INC 6.0%

Value $53.8M Shares 14,232,751 Est. Cost $1.87 Unrealized +90.8%

CRNX CRINETICS PHARMACEUTICALS IN 4.2%

Value $37.93M Shares 1,275,552 Est. Cost $18.69 Unrealized +10.3%

TNGX TANGO THERAPEUTICS INC 3.6%

Value $32.57M Shares 2,892,663 Est. Cost $10.01 Unrealized -39.1%

NTRA NATERA INC 3.5%

Value $30.98M Shares 700,197 Est. Cost $41.20 Unrealized +23.8%

CABA CABALETTA BIO INC 3.4%

Value $30.44M Shares 2,000,000 Est. Cost $10.85 Unrealized +25.9%

ACRS ACLARIS THERAPEUTICS INC 2.6%

Value $23.29M Shares 3,400,000 Est. Cost $12.69 Unrealized -32.7%

— EQRX INC 2.5%

Value $22.21M Shares 10,003,573 Est. Cost $6.82 Unrealized —

— X4 PHARMACEUTICALS INC 1.9%

Value $17.4M Shares 15,960,588 Est. Cost $2.66 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 1.8%

Value $15.93M Shares 3,000,000 Est. Cost $26.87 Unrealized -68.3%

NRIX NURIX THERAPEUTICS INC 1.6%

Value $14.33M Shares 1,822,883 Est. Cost $21.10 Unrealized -56.7%

— CYMABAY THERAPEUTICS INC 1.5%

Value $13.63M Shares 913,969 Est. Cost $8.72 Unrealized —

— DYNAVAX TECHNOLOGIES CORP 1.5%

Value $13.51M Shares 915,000 Est. Cost $9.83 Unrealized —

ANNX ANNEXON INC 1.5%

Value $13.46M Shares 5,701,926 Est. Cost $15.54 Unrealized -80.5%

— MARINUS PHARMACEUTICALS INC 1.3%

Value $11.52M Shares 1,431,058 Est. Cost $15.48 Unrealized —

— MERSANA THERAPEUTICS INC 1.2%

Value $11M Shares 8,663,673 Est. Cost $12.65 Unrealized —

RPID RAPID MICRO BIOSYSTEMS INC 1.0%

Value $9.109M Shares 8,434,560 Est. Cost $20.66 Unrealized -95.2%

SYRS SYROS PHARMACEUTICALS INC 0.9%

Value $8.393M Shares 2,124,694 Est. Cost $6.27 Unrealized -40.3%

SLDB SOLID BIOSCIENCES INC 0.9%

Value $7.889M Shares 3,130,422 Est. Cost $6.55 Unrealized -40.8%

AVIR ATEA PHARMACEUTICALS INC 0.8%

Value $7.457M Shares 2,485,638 Est. Cost $32.23 Unrealized -89.4%

NAUT NAUTILUS BIOTECHNOLOGY INC 0.7%

Value $6.32M Shares 2,000,000 Est. Cost $10.83 Unrealized -69.9%

XLO XILIO THERAPEUTICS INC 0.7%

Value $5.919M Shares 2,805,413 Est. Cost $17.03 Unrealized -84.4%

— 2SEVENTY BIO INC 0.6%

Value $5.523M Shares 1,408,901 Est. Cost $18.15 Unrealized —

IVVD INVIVYD INC 0.4%

Value $3.293M Shares 1,937,207 Est. Cost $37.11 Unrealized -95.7%

CCCC C4 THERAPEUTICS INC 0.3%

Value $3.055M Shares 1,642,210 Est. Cost $29.00 Unrealized -89.5%

NAMSW NEWAMSTERDAM PHARMA COMPANY 0.0%

Value $190K Shares 100,000 Est. Cost $0.86 Unrealized —

— CARA THERAPEUTICS INC 0.0%

Value $39,725 Shares 23,646 Est. Cost $9.16 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NUVL	NUVALENT INC	3,577,267	$164M	18.4%	$28.96	+53.2%	COM	670703107
PHVS	PHARVARIS N V	4,784,674	$99.86M	11.2%	$23.89	-22.8%	COM	N69605108
NAMS	NEWAMSTERDAM PHARMA COMPANY	10,473,913	$96.88M	10.8%	$10.64	+1.8%	ORDINARY SHARES	N62509109
—	SPRINGWORKS THERAPEUTICS INC	3,081,307	$71.24M	8.0%	$21.68	—	COM	85205L107
IRON	DISC MEDICINE INC	1,332,545	$62.6M	7.0%	$22.28	+124.5%	COM	254604101
SVRA	SAVARA INC	14,232,751	$53.8M	6.0%	$1.87	+90.8%	COM	805111101
CRNX	CRINETICS PHARMACEUTICALS IN	1,275,552	$37.93M	4.2%	$18.69	+10.3%	COM	22663K107
TNGX	TANGO THERAPEUTICS INC	2,892,663	$32.57M	3.6%	$10.01	-39.1%	COM	87583X109
NTRA	NATERA INC	700,197	$30.98M	3.5%	$41.20	+23.8%	COM	632307104
CABA	CABALETTA BIO INC	2,000,000	$30.44M	3.4%	$10.85	+25.9%	COM	12674W109
ACRS	ACLARIS THERAPEUTICS INC	3,400,000	$23.29M	2.6%	$12.69	-32.7%	COM	00461U105
—	EQRX INC	10,003,573	$22.21M	2.5%	$6.82	—	COM	26886C107
—	X4 PHARMACEUTICALS INC	15,960,588	$17.4M	1.9%	$2.66	—	COM	98420X103
ARQT	ARCUTIS BIOTHERAPEUTICS INC	3,000,000	$15.93M	1.8%	$26.87	-68.3%	COM	03969K108
NRIX	NURIX THERAPEUTICS INC	1,822,883	$14.33M	1.6%	$21.10	-56.7%	COM	67080M103
—	CYMABAY THERAPEUTICS INC	913,969	$13.63M	1.5%	$8.72	—	COM	23257D103
—	DYNAVAX TECHNOLOGIES CORP	915,000	$13.51M	1.5%	$9.83	—	COM NEW	268158201
ANNX	ANNEXON INC	5,701,926	$13.46M	1.5%	$15.54	-80.5%	COM	03589W102
—	MARINUS PHARMACEUTICALS INC	1,431,058	$11.52M	1.3%	$15.48	—	COM NEW	56854Q200
—	MERSANA THERAPEUTICS INC	8,663,673	$11M	1.2%	$12.65	—	COM	59045L106
RPID	RAPID MICRO BIOSYSTEMS INC	8,434,560	$9.109M	1.0%	$20.66	-95.2%	CLASS A COM	75340L104
SYRS	SYROS PHARMACEUTICALS INC	2,124,694	$8.393M	0.9%	$6.27	-40.3%	COM NEW	87184Q206
SLDB	SOLID BIOSCIENCES INC	3,130,422	$7.889M	0.9%	$6.55	-40.8%	COM NEW	83422E204
AVIR	ATEA PHARMACEUTICALS INC	2,485,638	$7.457M	0.8%	$32.23	-89.4%	COM	04683R106
NAUT	NAUTILUS BIOTECHNOLOGY INC	2,000,000	$6.32M	0.7%	$10.83	-69.9%	COM	63909J108
XLO	XILIO THERAPEUTICS INC	2,805,413	$5.919M	0.7%	$17.03	-84.4%	COM	98422T100
—	2SEVENTY BIO INC	1,408,901	$5.523M	0.6%	$18.15	—	COMMON STOCK	901384107
IVVD	INVIVYD INC	1,937,207	$3.293M	0.4%	$37.11	-95.7%	COM	00534A102
CCCC	C4 THERAPEUTICS INC	1,642,210	$3.055M	0.3%	$29.00	-89.5%	COM STK	12529R107
NAMSW	NEWAMSTERDAM PHARMA COMPANY	100,000	$190K	0.0%	$0.86	—	*W EXP 11/22/202	N62509117
—	CARA THERAPEUTICS INC	23,646	$39,725	0.0%	$9.16	—	COM	140755109